Abraham Kalikstein, MD | |
3003 New Hyde Park Rd, Ste 200, New Hyde Park, NY 11042-1214 | |
(516) 488-1888 | |
Not Available |
Full Name | Abraham Kalikstein |
---|---|
Gender | Male |
Speciality | Neurology |
Experience | 9 Years |
Location | 3003 New Hyde Park Rd, New Hyde Park, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245617927 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Long Island Jewish Medical Center | New hyde park, NY | Hospital |
North Shore University Hospital | Manhasset, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
New York Neurologic Associates Llp | 5991769846 | 7 |
News Archive
Karolinska Development AB today announced that the European Investment Fund (EIF) has entered into a co-investment agreement with the company. The co-investment fund will be managed by Karolinska Development and used to invest in the company's portfolio of early-stage pharmaceutical and medical technology companies.
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has issued a special news report on key developments at CEL-SCI Corporation.
For the first time, an immune checkpoint inhibitor has been proven to increase survival among patients with advanced renal cell carcinoma (RCC), a patient population for whom treatment options are currently limited.
Experts at the University of Alabama at Birmingham (UAB) say a man's tendency to wait until the onset of sickness to see his doctor is a major detriment to health because key screenings are missed.
The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection.
› Verified 5 days ago
Entity Name | New York Neurologic Associates Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083687198 PECOS PAC ID: 5991769846 Enrollment ID: O20041119000150 |
News Archive
Karolinska Development AB today announced that the European Investment Fund (EIF) has entered into a co-investment agreement with the company. The co-investment fund will be managed by Karolinska Development and used to invest in the company's portfolio of early-stage pharmaceutical and medical technology companies.
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has issued a special news report on key developments at CEL-SCI Corporation.
For the first time, an immune checkpoint inhibitor has been proven to increase survival among patients with advanced renal cell carcinoma (RCC), a patient population for whom treatment options are currently limited.
Experts at the University of Alabama at Birmingham (UAB) say a man's tendency to wait until the onset of sickness to see his doctor is a major detriment to health because key screenings are missed.
The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Abraham Kalikstein, MD 3003 New Hyde Park Rd, Ste 200, New Hyde Park, NY 11042-1214 Ph: (516) 488-1888 | Abraham Kalikstein, MD 3003 New Hyde Park Rd, Ste 200, New Hyde Park, NY 11042-1214 Ph: (516) 488-1888 |
News Archive
Karolinska Development AB today announced that the European Investment Fund (EIF) has entered into a co-investment agreement with the company. The co-investment fund will be managed by Karolinska Development and used to invest in the company's portfolio of early-stage pharmaceutical and medical technology companies.
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has issued a special news report on key developments at CEL-SCI Corporation.
For the first time, an immune checkpoint inhibitor has been proven to increase survival among patients with advanced renal cell carcinoma (RCC), a patient population for whom treatment options are currently limited.
Experts at the University of Alabama at Birmingham (UAB) say a man's tendency to wait until the onset of sickness to see his doctor is a major detriment to health because key screenings are missed.
The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection.
› Verified 5 days ago
Felicia Gliksman, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 410 Lakeville Rd, Suite 105, New Hyde Park, NY 11042 Phone: 516-465-5255 | |
Dr. Asiya Kabir, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 56 Grattan St, New Hyde Park, NY 11040 Phone: 718-460-0658 | |
Joanna Sabina Gedzior, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 270-05 76th Avenue Consultation Psychiatry, The North Shore - Long Island Jewish Health System, New Hyde Park, NY 11040 Phone: 718-470-4650 | |
Deepika R Ramchandani, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 1575 Hillside Ave, New Hyde Park, NY 11040 Phone: 516-328-9053 Fax: 516-705-3418 | |
Rose Marrie Sy-kho, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 410 Lakeville Rd, Suite 105, New Hyde Park, NY 11042 Phone: 516-465-5255 | |
Margarita Kats, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 26901 76th Ave, New Hyde Park, NY 11040 Phone: 000-000-0000 | |
Dr. Jordana Sara Schneider, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3003 New Hyde Park Rd Ste 200, New Hyde Park, NY 11042 Phone: 516-488-8888 |